Management of enterocutaneous fistulas

Surg Clin North Am. 2011 Jun;91(3):481-91. doi: 10.1016/j.suc.2011.02.004.

Abstract

Management of enterocutaneous fistulas (ECFs) involves (1) recognition and stabilization, (2) anatomic definition and decision, and (3) definitive operation. Phase 1 encompasses correction of fluid and electrolyte imbalance, skin protection, and nutritional support. Abdominal imaging defines the anatomy of the fistula in phase 2. ECFs that do not heal spontaneously require segmental resection of the bowel segment communicating with the fistula and restoration of intestinal continuity in phase 3. The enteroatmospheric fistula (EAF) is a malevolent condition requiring prolonged wound care and nutritional support. Complex abdominal wall reconstruction immediately following fistula resection is necessary for all EAFs.

Publication types

  • Review

MeSH terms

  • Cutaneous Fistula / classification
  • Cutaneous Fistula / therapy*
  • Enteral Nutrition
  • Hormones / therapeutic use
  • Humans
  • Intestinal Fistula / classification
  • Intestinal Fistula / therapy*
  • Octreotide / therapeutic use
  • Postoperative Complications / therapy*
  • Somatostatin / therapeutic use
  • Wound Healing / physiology

Substances

  • Hormones
  • Somatostatin
  • Octreotide